Showing results 10 to 12 of 12
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement Journal:Hong Kong Medical Journal | 2013 | 48 | ||
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment Journal:Clinical and Molecular Hepatology | 2020 | 18 | ||
Use of Glecaprevir/Pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment Proceeding/Conference:Hepatology International | 2019 | 38 |